JPRN-UMIN000004523尚未招募未知
Combination Therapy of RFA and Miriplatine Versus RFA for HCC larger than 3cm - Combination Therapy of RFA and Miriplatine Versus RFA
Osaka city University Graduate School of Medicine Department of Hepatotlogy0 个研究点目标入组 50 人开始时间: 2010年11月9日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •I.Patients who are considered not to participate in the study by physicians II.Patients with moderate or severe infections III.Patients with uncontrolled diabetes or obstruction IV.Pregnancy, nursing, or woman who may become pregnant V.Patients with a history of hypersensitivity to drugs or contrast agents containing iodine VI.Patients with a history of myocardial infarction within 3 month
研究者
相似试验
已完成
不适用
COMBINATION ANTI-PARATUBERCULOSIS THERAPY WITH RIFABUTIN, CLARITHROMYCIN AND CLOFAZIMINE FOR CROHNâ¿¿S DISEASE: A THREE YEAR PROSPECTIVE, RANDOMISED, PLACEBO-CONTROLLED, MULTICENTRE STUDYOral and Gastrointestinal - Crohn's diseaseCrohn's diseaseACTRN12605000429651Pfizer Australia212
进行中（未招募）
不适用
Rifampin combination therapy versus monotherapy in early staphylococcal infections after total hip and knee arthroplastyJoint prosthesis infection after total hip and knee arthroplasty.EUCTR2005-005494-29-NOllevål University Hospital200
招募中
1 期
The RiCOTTA trialCTIS2022-501620-26-00eiden University Medical Center316
进行中（未招募）
1 期
Assessment of Dual antiplatelet therapy versus Rivaroxaban In atrial Fibrillation patients Treated with left atrial appendage closure: The randomized ADRIFT Study - ADRIFTMedDRA version: 19.1 Level: PT Classification code 10003658 Term: Atrial fibrillation System Organ Class: 10007541 - Cardiac disordersEUCTR2017-001567-20-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)90
进行中（未招募）
不适用
Antiplatelet therapy in combination with Recombinant t-PA Thrombolysis in Ischemic Stroke - ARTISPatients with ischemic strokeMore specific patients with ischemic stroke treated with rt-PA thrombolysisEUCTR2006-006829-13-NLetherlands Heart Foundation1,000